Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
DRTS | US
-0.73
-7.60%
Healthcare
Biotechnology
30/06/2024
02/06/2026
8.93
9.65
9.66
8.86
Alpha Tau Medical Ltd. a clinical-stage oncology therapeutics company engages in research development and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin oral pancreatic prostate and breast cancers; and preclinical studies for brain hepatic cell carcinoma glioblastoma multiforme lung cancer and others. The company was incorporated in 2015 and is headquartered in Jerusalem Israel.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
101.0%1 month
121.1%3 months
85.1%6 months
87.6%-
-
2.13
0.17
0.13
-4.77
-
-
-35.22M
624.42M
624.42M
-
-
-
-
-33.17
1.60
0.08
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
2.76
Range1M
4.45
Range3M
5.52
Rel. volume
0.95
Price X volume
9.54M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Lexicon Pharmaceuticals Inc | LXRX | Biotechnology | 1.89 | 683.22M | -8.70% | n/a | 44.04% |
| Unicycive Therapeutics Inc. Common Stock | UNCY | Biotechnology | 7.23 | 682.20M | -4.87% | n/a | -315.38% |
| X4 Pharmaceuticals Inc | XFOR | Biotechnology | 4.04 | 680.74M | -1.70% | 4.00 | 82.82% |
| Rallybio Corporation Common Stock | RLYB | Biotechnology | 16.23 | 673.34M | -3.79% | n/a | 0.35% |
| EyePoint Pharmaceuticals Inc | EYPT | Biotechnology | 12.53 | 670.58M | -4.71% | n/a | 10.20% |
| Aceto Corporation | ACET | Drug Manufacturers-Specialty & Generic | 8.11 | 668.27M | -7.63% | n/a | 8.14% |
| PHATHOM PHARMACEUTICALS INC. | PHAT | Biotechnology | 9.65 | 658.99M | 4.44% | n/a | -216.56% |
| Esperion Therapeutics Inc | ESPR | Biotechnology | 3.14 | 637.29M | 0.32% | n/a | -161.71% |
| OLMA | OLMA | Biotechnology | 10.69 | 612.18M | -15.89% | n/a | 0.86% |
| Omeros Corporation | OMER | Biotechnology | 10.26 | 594.54M | -4.29% | n/a | -356.63% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Latham Group Inc. | SWIM | Building Products & Equipment | 5.32 | 614.87M | 0.00% | 65.18 | 77.00% |
| Malibu Boats Inc | MBUU | Recreational Vehicles | 27.52 | 550.14M | -1.75% | n/a | 1.50% |
| Ennis Inc | EBF | Building Products & Equipment | 20.73 | 539.06M | 0.63% | 13.28 | 2.28% |
| MCBC Holdings Inc | MCFT | Recreational Vehicles | 23.21 | 385.46M | -0.04% | 34.27 | 26.82% |
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 3.88 | 371.70M | -0.77% | n/a | 174.23% |
| Camping World Holdings Inc | CWH | Recreational Vehicles | 7.44 | 335.76M | -1.06% | n/a | 3644.76% |
| Urban One Inc | UONEK | Broadcasting - Radio | 4.7 | 249.14M | -10.36% | n/a | 268.43% |
| CPI Card Group Inc | PMTS | Building Products & Equipment | 16.74 | 186.78M | -0.42% | 15.61 | -621.78% |
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 11.36 | 182.41M | 2.53% | n/a | 286.96% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 40.57 | 116.51M | -0.44% | 5.16 | 19.82% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -4.77 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 2.13 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 85.08 | 72.80 | Par |
| Debt to Equity | 0.17 | -1.23 | Expensive |
| Debt to Assets | 0.13 | 0.25 | Cheaper |
| Market Cap | 624.42M | 3.66B | Emerging |